Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jaffe

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Human Genetics|July 1, 1986
Telomeric fusion in pre-T-cell acute lymphoblastic leukemiaR Morgan, V Jarzabek, J P Jaffe, et al.
Archives of Disease in Childhood|June 1, 1985
Toxic shock syndromeR Buchdahl, M Levin, B Wilkins, et al.
American Journal of Surgery|November 1, 1996
Clinical presentation and management of iatrogenic colon perforationsT M Gedebou, R A Wong, W D Rappaport, et al.
The American Journal of Gastroenterology|August 1, 1994
A normal initial colonoscopy after age 50 does not predict a polyp-free status for lifeS Squillace, P Berggreen, P Jaffe, et al.
Digestive Diseases and Sciences|November 26, 1999
Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activitiesR Fass, R Hell, R E Sampliner, et al.
Endoscopy|February 1, 1995
Experience with a catheter-based ultrasound probe in the bile duct and pancreasF Gress, Y K Chen, S Sherman, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2000
Managing heartburn at the 'base' of the GERD 'iceberg': effervescent ranitidine 150 mg b.d. provides faster and better heartburn relief than antacidsD Earnest, M Robinson, S Rodriguez-Stanley, et al.
The British Journal of Surgery|November 1, 1971
Observations on the effect of horse anti-pig leucocyte serum in suppressing the rejection of renal allografts in pigsH J White, M O Symes, M S Golby, et al.
Archives of Internal Medicine|November 25, 1998
Heartburn requiring frequent antacid use may indicate significant illnessM Robinson, D Earnest, S Rodriguez-Stanley, et al.
The Oncologist|January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Human Genetics|July 1, 1986
Telomeric fusion in pre-T-cell acute lymphoblastic leukemiaR Morgan, V Jarzabek, J P Jaffe, et al.
Archives of Disease in Childhood|June 1, 1985
Toxic shock syndromeR Buchdahl, M Levin, B Wilkins, et al.
American Journal of Surgery|November 1, 1996
Clinical presentation and management of iatrogenic colon perforationsT M Gedebou, R A Wong, W D Rappaport, et al.
The American Journal of Gastroenterology|August 1, 1994
A normal initial colonoscopy after age 50 does not predict a polyp-free status for lifeS Squillace, P Berggreen, P Jaffe, et al.
Digestive Diseases and Sciences|November 26, 1999
Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activitiesR Fass, R Hell, R E Sampliner, et al.
Endoscopy|February 1, 1995
Experience with a catheter-based ultrasound probe in the bile duct and pancreasF Gress, Y K Chen, S Sherman, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2000
Managing heartburn at the 'base' of the GERD 'iceberg': effervescent ranitidine 150 mg b.d. provides faster and better heartburn relief than antacidsD Earnest, M Robinson, S Rodriguez-Stanley, et al.
The British Journal of Surgery|November 1, 1971
Observations on the effect of horse anti-pig leucocyte serum in suppressing the rejection of renal allografts in pigsH J White, M O Symes, M S Golby, et al.
Archives of Internal Medicine|November 25, 1998
Heartburn requiring frequent antacid use may indicate significant illnessM Robinson, D Earnest, S Rodriguez-Stanley, et al.
The Oncologist|January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Pageof 6